Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wedemeyer

Showing results (321-330 of 1,142) with videos related to

Pageof 115
Sort By:
Deutsches Arzteblatt International|June 4, 2026
Malnutrition: Low Diagnosis and Treatment Rates in Hospitalized Patients. An Analysis of German Nationwide Health Insurance DataMonika Rau, Dominik Obermüller, Paul Ludwig, et al.
ACS Chemical Biology|February 15, 2023
Mechanistic Insight into the Suppression of Polyglutamine Aggregation by SRCP1Holly N Haver, Michael Wedemeyer, Erin Butcher, et al.
Frontiers in Transplantation|July 12, 2024
Combination of everolimus and low-dose tacrolimus controls histological liver allograft injury as sufficiently as high-dose tacrolimusEmily A Bosselmann, Fabian Dranicki, Alejandro Campos-Murguia, et al.
Zeitschrift Fur Gastroenterologie|January 15, 2005
Diagnostic algorithm for chronic hepatitis C virus infection: role of the new HCV-core antigen assayH L Tillmann, J Wiegand, I Glomb, et al.
The Journal of Urology|March 1, 1993
Evidence for urothelial cell activation in interstitial cystitisM Liebert, G Wedemeyer, J A Stein, et al.
Hepatology (Baltimore, Md.)|May 27, 2006
Caspase activation is required for antiviral treatment response in chronic hepatitis C virus infectionXandra Volkmann, Markus Cornberg, Heiner Wedemeyer, et al.
The Urologic Clinics of North America|August 11, 1991
Evaluation of a new bladder tumor markerH B Grossman, M Liebert, N Sakakibara, et al.
Plos One|December 23, 2025
Dynamic growth risk of incidentally detected gallbladder polyps-A retrospective, single-center analysisSophia Heinrich, Piet Janko Ten Thoren, Patrick Behrendt, et al.
Oncoimmunology|August 10, 2025
A preclinical model for the identification of therapeutically active transgenes in local cancer immunotherapyArne Menze, Dmitrij Ostroumov, Hans Heinrich Wedemeyer, et al.
Journal of Health Economics and Outcomes Research|September 4, 2023
Cost-effectiveness of Triple Therapy with Telaprevir for Chronic Hepatitis C Virus Patients in GermanyJona T Stahmeyer, Svenja Schauer, Siegbert Rossol, et al.
Pageof 115

Showing results (321-330 of 1,142) with videos related to

Sort By:
Pageof 115
Deutsches Arzteblatt International|June 4, 2026
Malnutrition: Low Diagnosis and Treatment Rates in Hospitalized Patients. An Analysis of German Nationwide Health Insurance DataMonika Rau, Dominik Obermüller, Paul Ludwig, et al.
ACS Chemical Biology|February 15, 2023
Mechanistic Insight into the Suppression of Polyglutamine Aggregation by SRCP1Holly N Haver, Michael Wedemeyer, Erin Butcher, et al.
Frontiers in Transplantation|July 12, 2024
Combination of everolimus and low-dose tacrolimus controls histological liver allograft injury as sufficiently as high-dose tacrolimusEmily A Bosselmann, Fabian Dranicki, Alejandro Campos-Murguia, et al.
Zeitschrift Fur Gastroenterologie|January 15, 2005
Diagnostic algorithm for chronic hepatitis C virus infection: role of the new HCV-core antigen assayH L Tillmann, J Wiegand, I Glomb, et al.
The Journal of Urology|March 1, 1993
Evidence for urothelial cell activation in interstitial cystitisM Liebert, G Wedemeyer, J A Stein, et al.
Hepatology (Baltimore, Md.)|May 27, 2006
Caspase activation is required for antiviral treatment response in chronic hepatitis C virus infectionXandra Volkmann, Markus Cornberg, Heiner Wedemeyer, et al.
The Urologic Clinics of North America|August 11, 1991
Evaluation of a new bladder tumor markerH B Grossman, M Liebert, N Sakakibara, et al.
Plos One|December 23, 2025
Dynamic growth risk of incidentally detected gallbladder polyps-A retrospective, single-center analysisSophia Heinrich, Piet Janko Ten Thoren, Patrick Behrendt, et al.
Oncoimmunology|August 10, 2025
A preclinical model for the identification of therapeutically active transgenes in local cancer immunotherapyArne Menze, Dmitrij Ostroumov, Hans Heinrich Wedemeyer, et al.
Journal of Health Economics and Outcomes Research|September 4, 2023
Cost-effectiveness of Triple Therapy with Telaprevir for Chronic Hepatitis C Virus Patients in GermanyJona T Stahmeyer, Svenja Schauer, Siegbert Rossol, et al.
Pageof 115